Exceeding 35,000ft², the new facility features an expanded class 10,000 clean room which is designed for manufacturing Finesse single use sensors. The building also includes an expanded floor
Under the contract, Cytovance will develop FB301 at its process development and analytical laboratories and manufacture at its 44,000ft² production facility. In addition, Cytovance will spearhead the cell
The ongoing double-blind 48-week trial is evaluating TAF 10mg/elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg with Stribild in treatment-naïve adults. A comparable virologic response was observed at 24 weeks of therapy
Catalyst licenses North America rights to Firdapse, an orphan drug that is in the Phase III trial for the treatment of Lambert-Eaton myasthenic syndrome (LEMS). According to the
Truppi in his new role is expected to increase business from US companies based in the Eastern half of North America, mainly focussing on Boston, Pennsylvania and New
Charles River, with the help of the acquisition, will provide research models and associated services for drug discovery and development in China. Charles River Laboratories chairman, president, and
The sale is part of Vion’s revised strategy to disinvest companies that are no longer part of the company’s core activities. Banner Pharmacaps manufactures proprietary softgel capsules for
Under the SC Proven brand, both the companies have launched the first product, ultra-primary human fibroblast cell line, which are believed to be starting material to generate human
The 4-in-1 nutrition shake, which is available in chocolate and vanilla flavors, includes the company’s proprietary Revigor ingredient and 13 grams of protein to help protect, preserve and
Spermatech, an early drug development company, identifies small molecules which can be developed into a non-hormonal male contraceptive. Dotmatics Platform will be used to manage and analyse data
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.